BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
See today's BioWorld MedTech
Home
» Terumo completes Quirem acquisition for interventional oncology boost
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Terumo completes Quirem acquisition for interventional oncology boost
July 20, 2020
By
Gina Lee
No Comments
HONG KONG – Tokyo-based Terumo Corp. has snapped up Dutch health care startup Quirem Medical BV, which develops selective internal radiation therapy (SIRT) microspheres to treat liver cancer.
BioWorld MedTech
Deals and M&A
Acquisition
Cancer
Asia-Pacific
Japan